Torray Investment Partners LLC Buys 8,506 Shares of The Cooper Companies, Inc. $COO

Torray Investment Partners LLC boosted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 52.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,822 shares of the medical device company’s stock after acquiring an additional 8,506 shares during the period. Torray Investment Partners LLC’s holdings in Cooper Companies were worth $2,034,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. JANA Partners Management LP bought a new position in Cooper Companies during the 3rd quarter worth $166,917,000. First American Bank bought a new position in Cooper Companies during the 3rd quarter worth $1,646,000. Rakuten Investment Management Inc. bought a new position in Cooper Companies during the 3rd quarter worth $11,341,000. Massachusetts Financial Services Co. MA boosted its holdings in shares of Cooper Companies by 96.9% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock valued at $212,519,000 after purchasing an additional 1,525,693 shares in the last quarter. Finally, Thompson Investment Management Inc. acquired a new stake in shares of Cooper Companies in the 3rd quarter valued at $3,728,000. Institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on COO. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $73.00 target price on shares of Cooper Companies in a report on Friday, January 9th. Rothschild & Co Redburn downgraded Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price on the stock. in a report on Wednesday, March 4th. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a report on Saturday, February 28th. William Blair raised Cooper Companies to a “strong-buy” rating in a report on Friday, January 30th. Finally, Weiss Ratings raised Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $90.79.

Cooper Companies Trading Down 1.2%

COO traded down $0.77 during midday trading on Thursday, hitting $66.15. 147,242 shares of the company were exchanged, compared to its average volume of 2,023,646. The firm has a market capitalization of $12.91 billion, a P/E ratio of 32.75, a P/E/G ratio of 1.74 and a beta of 1.07. The Cooper Companies, Inc. has a 1-year low of $61.78 and a 1-year high of $89.83. The firm’s 50 day moving average price is $74.84 and its 200-day moving average price is $76.50. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.03 by $0.07. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.